Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
169
NCT00510822
Cimicoxib for the Treatment of Major Depression (SECIM)
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2007
Completion: Feb 28, 2010